— Know what they know.
Not Investment Advice
Also trades as: CTEC.L (LSE) · $vol 22M · CNVVF (OTC) · $vol 0M

CNVVY OTC

ConvaTec Group Plc
1W: +3.3% 1M: -9.8% 3M: -2.8% YTD: -11.0% 1Y: -9.2% 3Y: +11.6% 5Y: +73.3%
$11.47
-0.07 (-0.61%)
 
Weekly Expected Move ±3.1%
$11 $11 $11 $12 $12
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 39 · $5.6B mcap · 396M float · 0.0072% daily turnover · Short 27% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.6B
52W Range10.45-14.093
Volume2,832
Avg Volume28,669
Beta0.84
Dividend$0.16
Analyst Ratings
6 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJonathan Peter Mason
Employees10,910
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2017-01-26
20 Eastbourne Terrace
London, GL W2 6LG
GB
44 11 8952 8100
About ConvaTec Group Plc

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse conditions such as diabetes, immobility, venous disease, traumatic injuries, burns, or complications following surgery. Furthermore, ConvaTec provides comprehensive ostomy care, including specialized devices, accessories, and support services for individuals living with a stoma, often necessitated by conditions like colorectal or bladder cancer, inflammatory bowel disease, obesity, among other medical reasons. Its product portfolio also extends to continence and critical care. This encompasses intermittent urinary catheters and solutions for managing bladder control issues linked to spinal cord injuries, multiple sclerosis, spina bifida, and various other urological disorders. Additionally, the firm supplies medical devices and products specifically designed for use in intensive care units (ICUs) and broader hospital settings. ConvaTec develops sophisticated systems for handling acute fecal incontinence, as well as for precise monitoring of urine production output and intra-abdominal pressure. A diverse array of disposable medical devices is also provided, featuring wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen/aerosol therapy, suction handles and tubing, gastroenterology tubes, and securement devices. The company is also a supplier of disposable infusion sets to manufacturers of insulin pumps for diabetic patients, and similar sets for pumps employed in continuous infusion treatments for other medical conditions. ConvaTec serves a broad spectrum of clients, including healthcare providers, patients, and other manufacturers. Its products reach both hospital and home healthcare markets, distributed through direct sales, as well as via distributors and wholesalers, targeting pharmacies, hospitals, and various acute and post-acute healthcare service providers. Established in 1978, the company's corporate headquarters are located in Reading, United Kingdom.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms